CoChat

Development of docetaxel liposome surface modified with CD133 aptamers for lung cancer targeting

Open access
Ma, Junzhe, Zhuang, Huiru, Zhuang, Zhixiang, Lu, Yufeng, Xia, Rui, Gan, Lei, Wu, Yuantao · 2017 · Artificial Cells, Nanomedicine, and Biotechnology
Cited by 45

The DOI matches its Crossref record.

Abstract

The aim of the present study was to prepare a novel CD133 aptamer modified DTX liposome system and investigate its characteristics in vitro and in vivo studies. In this study, the CD133-DTX LP was prepared by the thin-film hydration method and with the particle size of 100-120 nm. The TEM photomicrographs were smooth, sub-spherical in shape and aggregated to form small clusters. In vitro, a relatively slower DTX release profile was observed in CD133-DTX LP due to the presence of CD133 aptamers on the outer surface which might hinder the drug release. The drug release mechanism fit well with the Higuchi equation better. In cytotoxicity study, CD133 aptamers modified DTX LP significantly decreased cell proliferation and improved the therapeutic efficiency. In vivo imaging result indicated that CD133-DTX LP had very good tumour targeting ability. In vivo antitumour activity indicated that the CD133-DTX LP showed a significant antitumour activity in A549 tumour mice, with a very low systemic toxicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/21691401.2017.1394874

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 45

Metadata

Authors
Ma, J., Zhuang, H., Zhuang, Z., Lu, Y., Xia, R., Gan, L., & Wu, Y.
Venue
Artificial Cells, Nanomedicine, and Biotechnology
Published
2017-10-30
Volume
46
Issue
8
Pages
1-8
ISSN
  • 2169-1401 (ISSN-L)
  • 2169-141X
OpenAlex
W2767019153
Cited by
45
References
0
FWCI
1.26
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Development of docetaxel liposome surface modified with CD133 aptamers for lung cancer targeting. https://app.cochat.ai/papers/10.1080/21691401.2017.1394874
The paper
Ma, J., Zhuang, H., Zhuang, Z., Lu, Y., Xia, R., Gan, L., & Wu, Y. (2017). Development of docetaxel liposome surface modified with CD133 aptamers for lung cancer targeting. Artificial Cells, Nanomedicine, and Biotechnology. https://doi.org/10.1080/21691401.2017.1394874

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.